Increased expression of SMAD2 in reactive oral lesions as well as oral submucous fibrosis is in agreement with a study conducted by Moutasim et al., (2011), who also reported amplified expression of SMAD 2, 4 in archived tissue specimens of fibroepithelial hyperplasia. Here, SMAD2 is linked to oral submucous fibrosis.